J. S. Pober and W. C. Sessa, Evolving functions of endothelial cells in inflammation, Nat Rev Immunol, vol.7, pp.803-818, 2007.

J. S. Pober, W. Min, and J. R. Bradley, Mechanisms of endothelial dysfunction, injury, and death, Annu Rev Pathol, vol.4, pp.71-95, 2009.

R. Khokha, A. Murthy, and A. Weiss, Metalloproteinases and their natural inhibitors in inflammation and immunity, Nat Rev Immunol, vol.13, pp.649-65, 2013.

D. Dreymueller, J. Pruessmeyer, E. Groth, and A. Ludwig, The role of ADAM-mediated shedding in vascular biology, Eur J Cell Biol, vol.91, pp.472-85, 2012.

E. C. Bozkulak and G. Weinmaster, Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling, Mol Cell Biol, vol.29, pp.5679-95, 2009.

C. Hundhausen, D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig et al., The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion, Blood, vol.102, pp.1186-95, 2003.

K. Reiss, T. Maretzky, A. Ludwig, T. Tousseyn, B. De-strooper et al., ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and betacatenin nuclear signalling, EMBO J, vol.24, pp.742-52, 2005.

B. Schulz, J. Pruessmeyer, T. Maretzky, A. Ludwig, C. P. Blobel et al., ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin, Circ Res, vol.102, pp.1192-201, 2008.

M. Donners, I. Wolfs, S. Olieslagers, Z. Mohammadi-motahhari, V. Tchaikovski et al., A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis, Arterioscler Thromb Vasc Biol, vol.30, pp.2188-95, 2010.

C. Garbers, N. Jä-nner, A. Chalaris, M. L. Moss, D. M. Floss et al., Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) transsignaling and novel role of ADAM10 in inducible IL-6 receptor shedding, J Biol Chem, vol.286, pp.14804-14815, 2011.

T. Lieber, S. Kidd, and M. W. Young, Kuzbanian-mediated cleavage of Drosophila Notch, Genes Dev, vol.16, pp.209-230, 2002.

K. Glomski, S. Monette, K. Manova, D. Strooper, B. Saftig et al., Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures, Blood, vol.118, pp.1163-74, 2011.

E. Six, D. Ndiaye, Y. Laabi, C. Brou, N. Gupta-rossi et al., The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase

, Proc Natl Acad Sci, vol.100, pp.7638-7681, 2003.

S. Artavanis-tsakonas, M. D. Rand, and R. J. Lake, Notch signaling: cell fate control and signal integration in development, Science, vol.284, pp.770-776, 1999.

T. Iso, L. Kedes, and Y. Hamamori, HES and HERP families: multiple effectors of the Notch signaling pathway, J Cell Physiol, vol.194, pp.237-55, 2003.

C. J. Shawber and J. Kitajewski, Notch function in the vasculature: insights from zebrafish, mouse and man, BioEssays News Rev Mol Cell Dev Biol, vol.26, pp.225-259, 2004.

R. Benedito, C. Roca, I. Sö-rensen, A. S. Gossler, A. Fruttiger et al., The Notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis, Cell, vol.137, pp.1124-1159, 2009.

A. Haj-zen, A. Madeddu, and P. , Notch signalling in ischaemia-induced angiogenesis, Biochem Soc Trans, vol.37, pp.1221-1228, 2009.

H. Uyttendaele, J. Ho, J. Rossant, and J. Kitajewski, Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium, Proc Natl Acad Sci, vol.98, pp.5643-5651, 2001.

J. R. Shutter, S. Scully, W. Fan, W. G. Richards, J. Kitajewski et al., Dll4, a novel Notch ligand expressed in arterial endothelium, Genes Dev, vol.14, pp.1313-1321, 2000.

T. Quillard, J. Devalliè-re, S. Coupel, and B. Charreau, Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction, Biochem Pharmacol, vol.80, pp.2032-2073, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00637150

T. Quillard and B. Charreau, Impact of notch signaling on inflammatory responses in cardiovascular disorders, Int J Mol Sci, vol.14, pp.6863-88, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02165829

T. Quillard, S. Coupel, F. Coulon, J. Fitau, M. Chatelais et al., Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis, Arterioscler Thromb Vasc Biol, vol.28, pp.2258-65, 2008.

T. Quillard, J. Devalliere, M. Chatelais, F. Coulon, C. Sé-veno et al., Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin, PLoS ONE, vol.4, p.8244, 2009.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using realtime quantitative PCR and the 2(ÀDelta Delta C(T)) method. Methods, vol.25, pp.402-410, 2001.

G. Van-tetering, P. Van-diest, I. Verlaan, E. Van-der-wall, R. Kopan et al., Metalloprotease ADAM10 is required for Notch1 site 2 cleavage, J Biol Chem, vol.284, pp.31018-31045, 2009.

D. R. Gibb, E. Shikh, M. Kang, D. Rowe, W. J. et al., ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo, J Exp Med, vol.207, pp.623-658, 2010.

M. E. Gentle, A. Rose, L. Bugeon, and M. J. Dallman, Noncanonical Notch signaling modulates cytokine responses of dendritic cells to inflammatory stimuli, J Immunol, vol.189, pp.1274-84, 2012.

S. Jin, A. P. Mutvei, I. V. Chivukula, E. R. Andersson, D. Ramskö-ld et al., Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKa/IKKb, Oncogene, vol.32, pp.4892-902, 2013.

L. A. Madge and J. S. Pober, TNF signaling in vascular endothelial cells, Exp Mol Pathol, vol.70, pp.317-342, 2001.

J. Wang, L. Shelly, L. Miele, R. Boykins, M. A. Norcross et al., Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain, J Immunol, vol.167, pp.289-95, 1950.

Z. Liu, X. M. Balint, K. Soma, A. Pinnix, C. C. Capobianco et al., Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1, FASEB J Off Publ Fed Am Soc Exp Biol, vol.20, pp.1009-1020, 2006.

K. Uemura, T. Kihara, A. Kuzuya, K. Okawa, T. Nishimoto et al., Characterization of sequential N-cadherin cleavage by ADAM10 and PS1, Neurosci Lett, vol.402, pp.278-83, 2006.

D. Hartmann, B. De-strooper, L. Serneels, K. Craessaerts, A. Herreman et al., The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts, Hum Mol Genet, vol.11, pp.2615-2639, 2002.

D. Alfandari, C. Mccusker, and H. Cousin, ADAM function in embryogenesis, Semin Cell Dev Biol, vol.20, pp.153-63, 2009.

H. Diez, A. Fischer, A. Winkler, C. Hu, A. K. Hatzopoulos et al., Hypoxiamediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate, Exp Cell Res, vol.313, pp.1-9, 2007.

V. Caolo, N. Van-den-akker, S. Verbruggen, M. Donners, G. Swennen et al., Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells, J Biol Chem, vol.285, pp.40681-89, 2010.

M. B. Andrawes, X. Xu, H. Liu, S. B. Ficarro, J. A. Marto et al., Intrinsic selectivity of Notch 1 for Delta-like 4 over Delta-like 1, J Biol Chem, vol.288, pp.25477-89, 2013.

S. S. Liebler, A. Feldner, M. G. Adam, T. Korff, H. G. Augustin et al., No evidence for a functional role of bi-directional Notch signaling during angiogenesis, PLOS ONE, vol.7, p.53074, 2012.

C. K. Williams, J. Li, M. Murga, A. L. Harris, and G. Tosato, Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function, Blood, vol.107, pp.931-940, 2006.

G. Thurston, I. Noguera-troise, and G. D. Yancopoulos, The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth, Nat Rev Cancer, vol.7, pp.327-358, 2007.

Z. Liu, Y. Tan, G. W. Beecham, D. M. Seo, R. Tian et al., Notch activation induces endothelial cell senescence and pro-inflammatory response: implication of Notch signaling in atherosclerosis, Atherosclerosis, vol.225, pp.296-303, 2012.

K. J. Garton, P. J. Gough, J. Philalay, P. T. Wille, C. P. Blobel et al., Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17), J Biol Chem, vol.278, pp.37459-64, 2003.

H. H. Outtz, J. K. Wu, X. Wang, and J. Kitajewski, Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages, J Immunol, vol.185, pp.4363-73, 1950.

T. Ito, M. Schaller, C. M. Hogaboam, T. J. Standiford, M. Sandor et al., TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4, J Clin Invest, vol.119, pp.33-46, 2009.

S. Mukherjee, M. A. Schaller, R. Neupane, S. L. Kunkel, and N. W. Lukacs, Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation, J Immunol, vol.182, pp.7381-7389, 1950.

C. Taflin, B. Favier, J. Baudhuin, A. Savenay, P. Hemon et al., Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions, Proc Natl Acad Sci, vol.108, pp.2891-2897, 2011.